APP and fragile X syndrome: APP metabolism has been studied in the context of a variety of neurodevelopmental disorders including idiopathic autism, Angelman Syndrome, and FXS (Sokol et al., 2006; Ray et al., 2011; Erickson et al., 2014, 2016; Ray et al., 2016; Westmark et al., 2016b).